Pfizer increases 2021 sales forecast for Covid-19 vaccine to $ 26 billion

class = “cf”>

Pfizer has announced its balance sheet for the first quarter of this year.

According to the company statement, Pfizer’s sales for the first quarter of this year reached $ 14.6 billion, up 45% from the same period of 2020. The company’s net sales over the same period last year were made at $ 10.1 billion.

Pfizer’s revenue from vaccine sales was $ 4.9 billion in the first quarter of this year, while Kovid-19 vaccine sales revenue was $ 3.5 billion.

The company said it expects $ 26 billion in revenue this year from the Kovid-19 vaccine, which it developed with German biotech company BioNTech. Pfizer, in a statement in February, said they expected to generate $ 15 billion in revenue this year from vaccine sales.

Pfizer noted that 1.6 billion doses of the vaccine are expected to be delivered this year under contracts signed since mid-April.

class = “cf”>

The company’s net profit rose to $ 4.9 billion in the first quarter of this year. The company’s net profit for the same period last year was $ 3.4 billion.

Pfizer’s earnings per share, which was $ 0.63 in the first quarter of last year, rose to $ 0.93 in the same period of 2021.

Bigpara for cryptocurrency markets

Bigpara for cryptocurrency markets

Add a Comment